Home Studies Recruiting Metformin for the management of insulin resistance in overweight women at midlife

Metformin for the management of insulin resistance in overweight women at midlife

Description of the study:

The purpose of this project is to assess the effects of Metformin on insulin sensitivity (which helps prevent progression to type 2 diabetes), weight loss and lipids such as cholesterol. This study runs for 6 months and involves taking an oral study medication or placebo for this period. The participant is required to visit the study centre 4 times for medical assessments and observations.

Inclusion criteria
- Aged between 45 and 65 years 
- No use of systemic hormones in the past 3 months 
- A
BMI
>30kg/m2 and <40kg/m2 and a waist circumference >88cm 
- Post menopausal 
- In good health

Ethics Approval
Monash University Human Research Ethics Committee-MUHREC Project Number: CF10/1417 – 2010000757 (WHP 2010/9)

Geographical location of study
Prahran

Principal Investigator:

Professor Susan Davis

Contact details
For more information please contact us on: Phone: (03) 9903 0820 Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Website:http://womenshealth.med.monash.edu.au

Content updated 6 October 2010

 

Last Updated (Monday, 30 April 2012 09:30)